Companion Diagnostics Markets, 2025 - Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing - ResearchAndMarkets.com

DUBLIN--()--The "Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global companion diagnostics market grew at a CAGR of around 15% during 2014-2019.

Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.

The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market.

Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth.

Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies.

Looking forward, the global companion diagnostics market to continue its strong growth during the next five years.

Key Questions Answered in This Report:

  • How has the global companion diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global companion diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product & services?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global companion diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Companion Diagnostics Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Product & Service

6.1 Assays, Kits and Reagents

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Software and Services

7 Market Breakup by Technology

7.1 Immunohistochemistry (IHC)

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Polymerase Chain Reaction (PCR)

7.3 In-situ Hybridization (ISH)

7.4 Real-time PCR (RT-PCR)

7.5 Gene Sequencing

7.6 Others

8 Market Breakup by Indication

8.1 Cancer

8.1.1 Market Trends

8.1.2 Major Types

8.1.2.1 Lung Cancer

8.1.2.2 Breast Cancer

8.1.2.3 Colorectal Cancer

8.1.2.4 Gastric Cancer

8.1.2.5 Melanoma

8.1.2.6 Others

8.1.3 Market Forecast

8.2 Neurological Diseases

8.3 Infectious Diseases

8.4 Cardiovascular Diseases

8.5 Others

9 Market Breakup by End User

9.1 Pharmaceutical & Biopharmaceutical Companies

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 Reference Laboratories

9.3 Contract Research Organizations

9.4 Others

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux
  • Danaher Corporation
  • Roche Holding AG
  • Myriad Genetics Inc.
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/x6cy5v

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900